Mayo Clinic

Ulcerative colitis treatment reduces need for surgery by almost half

ROCHESTER, Minn -- A new study led by Mayo Clinic researchers has found that ulcerative colitis patients had a 41 percent reduction in colectomy after a year when treated with infliximab, according to a study published in the October 2009 issue of Gastroenterology.

Mayo researchers find gene that contributes to 2 different, common neurological movement disorders

JACKSONVILLE, Fla. -- Researchers at the Mayo Clinic campus in Florida and their collaborators worldwide have discovered that a single gene promotes development of essential tremor in some patients and Parkinson's disease in others. These are two common but distinct neurological disorders.

Study results raise questions about vertebroplasty for osteoporotic spinal compression fractures

ROCHESTER, Minn. -- A new study led by Mayo Clinic researchers has found that relief of pain from vertebral compression fractures, as well as improvement in pain-related dysfunction, were similar in patients treated with vertebroplasty and those treated with simulated vertebroplasty without cement injections.

Improved DNA stool test could detect digestive cancers in multiple organs

ROCHESTER, Minn. -- Mayo Clinic researchers have demonstrated that a noninvasive screening test can detect not only colorectal cancer but also the common cancers above the colon -- including pancreas, stomach, biliary and esophageal cancers. This is one of more than 100 Mayo Clinic studies being presented at Digestive Disease Week 2009 in Chicago, May 30 -- June 4.

Hormone therapy offers potential protective effect against colon cancer in older women

DENVER -- In a large study, a national team of researchers led by Mayo Clinic scientists observed that self-reported use of hormone therapy was associated with a significantly lower colorectal canc

2 comments
Read more
516 reads

Mayo Clinic-led researchers confirm gene variants associated with the most common adult leukemia

DENVER - A national team of researchers led by Mayo Clinic has found that patients with chronic lymphocytic leukemia (CLL) are more likely to have similar DNA changes or variants in up to six genes, compared to people who do not have the cancer.